LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,415,554
تعداد دریافت فایل اصل مقاله11,291,365
Rokhtabnak, Faranak, Safari, Saeed, Djalali Motlagh, Soudabeh, Yavari, Toktam, Pardis, Elham. (1402). Comparison of the Onset of Action, Maintenance, and Recovery of Three Weight-based Dosing of Cisatracurium in Patients with Morbid Obesity in Laparoscopic Bariatric Surgery: A Randomized Clinical Trial. سامانه مدیریت نشریات علمی, 48(6), 563-571. doi: 10.30476/ijms.2023.96131.2762
Faranak Rokhtabnak; Saeed Safari; Soudabeh Djalali Motlagh; Toktam Yavari; Elham Pardis. "Comparison of the Onset of Action, Maintenance, and Recovery of Three Weight-based Dosing of Cisatracurium in Patients with Morbid Obesity in Laparoscopic Bariatric Surgery: A Randomized Clinical Trial". سامانه مدیریت نشریات علمی, 48, 6, 1402, 563-571. doi: 10.30476/ijms.2023.96131.2762
Rokhtabnak, Faranak, Safari, Saeed, Djalali Motlagh, Soudabeh, Yavari, Toktam, Pardis, Elham. (1402). 'Comparison of the Onset of Action, Maintenance, and Recovery of Three Weight-based Dosing of Cisatracurium in Patients with Morbid Obesity in Laparoscopic Bariatric Surgery: A Randomized Clinical Trial', سامانه مدیریت نشریات علمی, 48(6), pp. 563-571. doi: 10.30476/ijms.2023.96131.2762
Rokhtabnak, Faranak, Safari, Saeed, Djalali Motlagh, Soudabeh, Yavari, Toktam, Pardis, Elham. Comparison of the Onset of Action, Maintenance, and Recovery of Three Weight-based Dosing of Cisatracurium in Patients with Morbid Obesity in Laparoscopic Bariatric Surgery: A Randomized Clinical Trial. سامانه مدیریت نشریات علمی, 1402; 48(6): 563-571. doi: 10.30476/ijms.2023.96131.2762

Comparison of the Onset of Action, Maintenance, and Recovery of Three Weight-based Dosing of Cisatracurium in Patients with Morbid Obesity in Laparoscopic Bariatric Surgery: A Randomized Clinical Trial

Iranian Journal of Medical Sciences
مقاله 5، دوره 48، شماره 6، بهمن و اسفند 2023، صفحه 563-571    اصل مقاله (685.4 K)
نوع مقاله: Original Article(s)
شناسه دیجیتال (DOI): 10.30476/ijms.2023.96131.2762
نویسندگان
Faranak Rokhtabnak1؛ Saeed Safari2؛ Soudabeh Djalali Motlagh* 1؛ Toktam Yavari1؛ Elham Pardis1
1Department of Anesthesiology, Pain and Intensive Care Medicine, Firoozgar General Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2Department of General Surgery and MIS, Firoozgar General Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
چکیده
Background: For patients with morbid obesity, different cisatracurium dosage regimens are recommended. This study aimed to compare the onset of action, the sufficiency of neuromuscular blockade during infusion, and the recovery of the three distinct cisatracurium dosage scalars in patients with morbid obesity undergoing laparoscopic bariatric surgery.
Methods: In this randomized clinical trial, 55 patients were scheduled for bariatric surgery at Firoozgar Hospital from March 2020 to August 2021. Using a block randomization method, they were randomly divided into three groups, based on total body weight (TBW group), fat-free mass (FFM group), or ideal body weight (IBW group), to receive a bolus of cisatracurium 0.2 mg/Kg, followed by an infusion of 2 µg/Kg, to maintain a train-of-four (TOF) count≤2. Data were analyzed using SPSS software. P<0.05 was considered statistically significant. 
Results: The mean time (seconds) to reach TOF0 in the TBW group was significantly shorter (201.89, 95%CI=192.99-210.79; P=0.004) than the IBW group (233.53, 95%CI=218.71-248.34; P=0.01). However, this difference was not statistically significant between TBW and FFM groups (220.83, 95%CI=199.73-241.94; P=0.81) or between FFM and the IBW groups (P=0.23). The rescue dose and increments of cisatracurium infusion were not required in the TBW group, whereas their probability was 4.81 times higher in the IBW group than the FFM group. Furthermore, the TBW and FFM groups had higher mean surgical condition scores than the IBW group (P<0.001, and P=0.006, respectively). 
Conclusion: Cisatracurium loading and infusion dosing based on FFM provide a comparable onset of action and surgical field condition to the TBW-based dosing with a shorter recovery time. However, IBW-based dosing of cisatracurium was insufficient for laparoscopic bariatric surgery. 
Trial Registration Number: IRCT20151107024909N9.

تازه های تحقیق

Faranak Rokhtabnak (Google Scholar)

Soudabeh Djalali Motlagh (Google Scholar)

کلیدواژه‌ها
Anesthesia؛ Bariatric surgery؛ Clinical trial؛ Morbid obesity
سایر فایل های مرتبط با مقاله
مراجع
  1. Fruh SM. Obesity: Risk factors, complications, and strategies for sustainable long-term weight management. J Am Assoc Nurse Pract. 2017;29:S3-S14. doi: 10.1002/2327-6924.12510. PubMed PMID: 29024553; PubMed Central PMCID: PMCPMC6088226.
  2. Mafort TT, Rufino R, Costa CH, Lopes AJ. Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function. Multidiscip Respir Med. 2016;11:28. doi: 10.1186/s40248-016-0066-z. PubMed PMID: 27408717; PubMed Central PMCID: PMCPMC4940831.
  3. Noria SF, Grantcharov T. Biological effects of bariatric surgery on obesity-related comorbidities. Can J Surg. 2013;56:47-57. doi: 10.1503/cjs.036111. PubMed PMID: 23351555; PubMed Central PMCID: PMCPMC3569476.
  4. Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016;22:s176-85. PubMed PMID: 27356115.
  5. Peterli R, Wolnerhanssen BK, Peters T, Vetter D, Kroll D, Borbely Y, et al. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial. JAMA. 2018;319:255-65. doi: 10.1001/jama.2017.20897. PubMed PMID: 29340679; PubMed Central PMCID: PMCPMC5833546.
  6. Rebelos E, Dadson P, Oikonen V, Iida H, Hannukainen JC, Iozzo P, et al. Renal hemodynamics and fatty acid uptake: effects of obesity and weight loss. Am J Physiol Endocrinol Metab. 2019;317:E871-E8. doi: 10.1152/ajpendo.00135.2019. PubMed PMID: 31550182.
  7. Brill MJ, Diepstraten J, van Rongen A, van Kralingen S, van den Anker JN, Knibbe CA. Impact of obesity on drug metabolism and elimination in adults and children. Clin Pharmacokinet. 2012;51:277-304. doi: 10.2165/11599410-000000000-00000. PubMed PMID: 22448619.
  8. de Hoogd S, Valitalo PAJ, Dahan A, van Kralingen S, Coughtrie MMW, van Dongen EPA, et al. Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide. Clin Pharmacokinet. 2017;56:1577-87. doi: 10.1007/s40262-017-0544-2. PubMed PMID: 28510797; PubMed Central PMCID: PMCPMC5694499
  9. Leykin Y, Pellis T, Lucca M, Lomangino G, Marzano B, Gullo A. The effects of cisatracurium on morbidly obese women. Anesth Analg. 2004;99:1090-4. doi: 10.1213/01.ANE.0000132781.62934.37. PubMed PMID: 15385356.
  10. Brull SJ, Meistelman C, Gropper M, Miller R. Pharmacology of neuromuscular blocking drugs. Miller’s anesthesia. Philadelphia: Elsevier; 2020. p. 792-831.
  11. Petitpain N, Argoullon L, Masmoudi K, Fedrizzi S, Cottin J, Latarche C, et al. Neuromuscular blocking agents induced anaphylaxis: Results and trends of a French pharmacovigilance survey from 2000 to 2012. Allergy. 2018;73:2224-33. doi: 10.1111/all.13456. PubMed PMID: 29654608.
  12. Moon TS, SB J. Nutritional diseases: obesity and malnutrition. Stoelting’s Anesthesia and Co-Existing Disease. Philadelphia: Elsevier. 2022. 390p.
  13. Plaud B, Baillard C, Bourgain JL, Bouroche G, Desplanque L, Devys JM, et al. Guidelines on muscle relaxants and reversal in anaesthesia. Anaesth Crit Care Pain Med. 2020;39:125-42. doi: 10.1016/j.accpm.2020.01.005. PubMed PMID: 31926308.
  14. Ingrande J, Lemmens HJ. Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth. 2010;105:i16-23. doi: 10.1093/bja/aeq312. PubMed PMID: 21148651.
  15. van Kralingen S, van de Garde EM, Knibbe CA, Diepstraten J, Wiezer MJ, van Ramshorst B, et al. Comparative evaluation of atracurium dosed on ideal body weight vs. total body weight in morbidly obese patients. Br J Clin Pharmacol. 2011;71:34-40. doi: 10.1111/j.1365-2125.2010.03803.x. PubMed PMID: 21143499; PubMed Central PMCID: PMCPMC3018024.
  16. Martini CH, Boon M, Bevers RF, Aarts LP, Dahan A. Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. Br J Anaesth. 2014;112:498-505. doi: 10.1093/bja/aet377. PubMed PMID: 24240315.
  17. Anderson D, Burnham K. Model selection and multi-model inference. Second NY: Springer-Verlag. 2004;63:10.
  18. Frank EH. Regression modeling strategies with applications to linear models, logistic and ordinal regression, and survival analysis. Philadelphia: Spinger; 2015.
  19. Royston P, Sauerbrei W. Stability of multivariable fractional polynomial models with selection of variables and transformations: a bootstrap investigation. Stat Med. 2003;22:639-59. doi: 10.1002/sim.1310. PubMed PMID: 12590419.
  20. Liang X, Chen X, Li J, Yan M, Yang Y. Study on body composition and its correlation with obesity: A Cohort Study in 5121 Chinese Han participants. Medicine (Baltimore). 2018;97:e10722. doi: 10.1097/MD.0000000000010722. PubMed PMID: 29794748; PubMed Central PMCID: PMCPMC6392896.
  21. Brocks DR, Ben-Eltriki M, Gabr RQ, Padwal RS. The effects of gastric bypass surgery on drug absorption and pharmacokinetics. Expert Opin Drug Metab Toxicol. 2012;8:1505-19. doi: 10.1517/17425255.2012.722757. PubMed PMID: 22998066.
  22. Leskinen T, Eloranta AM, Tompuri T, Saari A, Ollila H, Makela J, et al. Changes in body composition by age and obesity status in preschool-aged children: the STEPS study. Eur J Clin Nutr. 2021;75:57-65. doi: 10.1038/s41430-020-0678-4. PubMed PMID: 32647366.
  23. Lafortuna CL, Maffiuletti NA, Agosti F, Sartorio A. Gender variations of body composition, muscle strength and power output in morbid obesity. Int J Obes (Lond). 2005;29:833-41. doi: 10.1038/sj.ijo.0802955. PubMed PMID: 15917862.
  24. Hall KD. Body fat and fat-free mass inter-relationships: Forbes’s theory revisited. Br J Nutr. 2007;97:1059-63. doi: 10.1017/S0007114507691946. PubMed PMID: 17367567; PubMed Central PMCID: PMCPMC2376748.
  25. Bera TK. Bioelectrical Impedance Methods for Noninvasive Health Monitoring: A Review. J Med Eng. 2014;2014:381251. doi: 10.1155/2014/381251. PubMed PMID: 27006932; PubMed Central PMCID: PMCPMC4782691.
  26. McLester CN, Nickerson BS, Kliszczewicz BM, McLester JR. Reliability and Agreement of Various InBody Body Composition Analyzers as Compared to Dual-Energy X-Ray Absorptiometry in Healthy Men and Women. J Clin Densitom. 2020;23:443-50. doi: 10.1016/j.jocd.2018.10.008. PubMed PMID: 30472111.
  27. Geng Z, Wu X. [Neuromuscular effects of cisatracurium besylate in obese patients]. Zhonghua Yi Xue Za Zhi. 2014;94:2844-6. PubMed PMID: 25534104.
  28. Torensma B, Martini CH, Boon M, Olofsen E, In ‘t Veld B, Liem RS, et al. Deep Neuromuscular Block Improves Surgical Conditions during Bariatric Surgery and Reduces Postoperative Pain: A Randomized Double Blind Controlled Trial. PLoS One. 2016;11:e0167907. doi: 10.1371/journal.pone.0167907. PubMed PMID: 27936214; PubMed Central PMCID: PMCPMC5148011
  29. Fuchs-Buder T, Schmartz D, Baumann C, Hilt L, Nomine-Criqui C, Meistelman C, et al. Deep neuromuscular blockade improves surgical conditions during gastric bypass surgery for morbid obesity: A randomised controlled trial. Eur J Anaesthesiol. 2019;36:486-93. doi: 10.1097/EJA.0000000000000996. PubMed PMID: 30985536.
  30. Hanley MJ, Abernethy DR, Greenblatt DJ. Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet. 2010;49:71-87. doi: 10.2165/11318100-000000000-00000. PubMed PMID: 20067334.
  31. Li JY, Zou QR, Peng XM. Pharmacokinetics of a cisatracurium dose according to fat-free mass for anesthesia induction in morbidly obese patients. Nan Fang Yi Ke Da Xue Xue Bao. 2016;36:1396-400. PubMed PMID: 27777205.
آمار
تعداد مشاهده مقاله: 3,468
تعداد دریافت فایل اصل مقاله: 582


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب